2022
Strengthening systems of care for people with or at risk for HIV, HCV and opioid use disorder: a call for enhanced data collection
Eller AJ, DiDomizio EE, Madden LM, Oliva JD, Altice FL, Johnson KA. Strengthening systems of care for people with or at risk for HIV, HCV and opioid use disorder: a call for enhanced data collection. Annals Of Medicine 2022, 54: 1714-1724. PMID: 35775786, PMCID: PMC9377256, DOI: 10.1080/07853890.2022.2084154.Peer-Reviewed Original ResearchConceptsCascade of careHuman immunodeficiency virusOpioid use disorderHepatitis C virusPublic health planningUse disordersCo-occurring opioid use disorderHealth planningBurden of diseaseSystems of careQuality improvement activitiesOUD cascadeTreatment initiationImmunodeficiency virusC virusPatient outcomesTreatment accessPayer sourceTreatment retentionHealth systemHealthcare systemCareSyndemicDisordersVirus
2021
Chapter 9 Outpatient opioid use disorder treatment for the ID physician
Muthulingam D, Madden L, Altice F. Chapter 9 Outpatient opioid use disorder treatment for the ID physician. 2021, 161-187. DOI: 10.1016/b978-0-323-68328-9.00009-6.Peer-Reviewed Original ResearchOpioid use disorderOUD treatmentOpioid use disorder treatmentExtended-release naltrexoneInfectious disease cliniciansInitiation of treatmentSpecial clinical considerationsUse disorder treatmentHIV practiceID cliniciansOUD pharmacotherapyIntegrated care deliveryID physiciansMedication optionsOpioid epidemicTreatment expansionTreatment accessUse disordersAddiction specialistsClinical considerationsOUD managementDisorder treatmentGeneral IDCare deliveryPractice settings
2015
Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective
Springer SA, Larney S, Alam-mehrjerdi Z, Altice FL, Metzger D, Shoptaw S. Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2015, 69: s155-s161. PMID: 25978482, PMCID: PMC4443704, DOI: 10.1097/qai.0000000000000637.Peer-Reviewed Original ResearchConceptsMedication-assisted therapyDrug treatmentAntiretroviral therapyHIV transmission riskNew HIV infectionsHarm reduction servicesSubstance use disordersPoor treatment accessImplementation of interventionsOpioid useHIV infectionEvidence-based practiceHIV preventionOpioid addictionTreatment accessUse disordersReduction servicesSexual riskTransmission riskTherapyWomenTreatmentDrugsImpressive lackSignificant reduction“Bureaucracy & Beliefs”: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine
Bojko MJ, Mazhnaya A, Makarenko I, Marcus R, Dvoriak S, Islam Z, Altice FL. “Bureaucracy & Beliefs”: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine. Drugs Education Prevention And Policy 2015, 22: 255-262. PMID: 27087758, PMCID: PMC4831711, DOI: 10.3109/09687637.2015.1016397.Peer-Reviewed Original ResearchOpioid substitution therapySubstitution therapySide effectsEvidence-based HIV prevention strategiesOpioid-dependent PWIDHIV prevention strategiesMulti-level barriersImplementation science projectHIV preventionMethadone clientsTreatment accessWaiting listPWIDPrevention strategiesTreatment attitudesSocial marketing campaignFree treatmentTreatment slotsTreatmentPublic healthTherapyFocus group discussionsDrugsStructural barriersParticipants
2007
HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine—programme description and policy implications
Bruce RD, Dvoryak S, Sylla L, Altice FL. HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine—programme description and policy implications. International Journal Of Drug Policy 2007, 18: 326-328. PMID: 17689382, PMCID: PMC2084072, DOI: 10.1016/j.drugpo.2006.12.011.Peer-Reviewed Original ResearchConceptsBuprenorphine maintenance therapyInjection drug useAnti-retroviral therapySubstitution therapyDrug useAddition of methadoneAdministration of buprenorphineHIV-1 seropositivityOpiate substitution therapyOverall health outcomesIllicit drug useCost of buprenorphineHIV treatment accessMaintenance therapyOpioid dependenceHIV casesEntry criteriaTreatment accessBuprenorphineDrug usersHealth outcomesMultidisciplinary teamTherapyGlobal Fund resourcesAdministration
1995
Women Living with Drug Abuse and HIV Disease: Drug Abuse Treatment Access and Secondary Prevention Issues
Weissman G, Melchior L, Huba G, Smereck G, Needle R, McCarthy S, Jones A, Genser S, Cottler L, Booth R, Altice F. Women Living with Drug Abuse and HIV Disease: Drug Abuse Treatment Access and Secondary Prevention Issues. Journal Of Psychoactive Drugs 1995, 27: 401-411. PMID: 8788695, DOI: 10.1080/02791072.1995.10471704.Peer-Reviewed Original ResearchConceptsHIV secondary preventionDrug abuse treatment servicesDrug abuse treatmentSecondary preventionTreatment servicesAbuse treatmentDrug abuseOutpatient drug-free treatmentSecondary prevention issuesDrug-free treatmentDrug abuse treatment systemFirst yearHIV diseaseInjection drugsService utilizationTreatment accessDrug abusersDrug usersTreatment availabilityPositive findingsOutpatient drug abuse treatmentHealth resourcesDrug detoxificationWomenPrevention issues